Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Long acting risperidone cuts admissions

Risperidone long-acting injections can cut hospital admissions for people with schizophrenia, a UK study shows.

Records for 100 patients with schizophrenia who had completed 12 months on risperidone long-acting injections showed a significant reduction in hospital admissions - from 0.62 per person-year to 0.24.

The researchers said the reduction in hospital admissions was a good indicator of a lower chance of relapse – an important finding as 45% of patients in the study were switched to long-acting injections from other medications because of poor compliance.

Adherence to medication is known to be a key factor in relapse prevention, say the authors.

Journal of Psychopharmacology 2008; 22: 128-131

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say